Review: interferon and nucleoside/tide analogues reduce risk of hepato-cellular cancer in chronic hepatitis B
- PMID: 19483035
- DOI: 10.1136/ebm.14.3.86
Review: interferon and nucleoside/tide analogues reduce risk of hepato-cellular cancer in chronic hepatitis B
Comment on
-
Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma.Aliment Pharmacol Ther. 2008 Nov 1;28(9):1067-77. doi: 10.1111/j.1365-2036.2008.03816.x. Epub 2008 Jul 24. Aliment Pharmacol Ther. 2008. PMID: 18657133
Publication types
LinkOut - more resources
Full Text Sources